Laura Tan Lafave, MD

NPI 1750463030ActiveIndividual· Internal Medicine, Endocrinology, Diabetes & Metabolism· Minneapolis, MN

Internal Medicine, Endocrinology, Diabetes & Metabolism (MD) in Minneapolis, Minnesota, trained at University of Minnesota Medical School (class of 2001). Their prescriptions cost Medicare Part D more than their services did: $820,489 for 2,258 claims, against $11,730 paid for services in 2024. Abbott Laboratories was the largest of 2 companies reporting payments in 2024, $36.92 in all, mostly device and supply loans.

Overview

NPI	1750463030
Status	Active
Entity type	Individual
Credential	MD
Sole proprietor	No
NPI issued	Oct 19, 2006
Last updated in NPPES	Feb 20, 2026
Certified by provider	Feb 20, 2026

Specialties and licenses

Taxonomy	Code	License	State
Internal Medicine, Endocrinology, Diabetes & Metabolism Primary	207RE0101X	102653	MN

About license numbers in NPPES

Exclusion screening

List	Result	Details
HHS-OIG LEIE · Nov 10, 2026	No match	Checked by NPI and by name + state
North Carolina Medicaid · Nov 11, 2026	No match	—
New York OMIG · Nov 11, 2026	No match	—
Ohio Medicaid · Nov 11, 2026	No match	—
Pennsylvania Medicheck · Nov 11, 2026	No match	—
Washington HCA · Nov 11, 2026	No match	—

Official OIG search · How matching works ·Bulk check a roster

Medicare

Enrollment (PECOS)	Enrolled Practitioner - Endocrinology (MN)
Accepts assignment	Yes (participating)

Medicare services in 2024

Medicare patients	114
Services billed	182 across 19 procedure codes
Paid by Medicare	$11,730

Part D prescriptions in 2024

Prescriptions (claims)	2,258 · 3,780 30-day fills
Patients	302
Total drug cost	$820,489
Generic share	34% of claims

Medicare sources and data years

Education and affiliations

Medical school	University of Minnesota Medical School
Graduation year	2001
Medicare specialty	Endocrinology
Secondary specialties	Internal Medicine
Telehealth	Offers telehealth